alexa Supplier Management - Key Components Of Managing Suppliers In A CGMP Environment
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Summit on GMP, GCP & Quality Control
November 12-14, 2013 DoubleTree by Hilton Hotel Chicago-North Shore, IL, USA

Pejman Parhami
ScientificTracks Abstracts: J Develop Drugs
DOI: 10.4172/2329-6631.S1.002
FDA holds pharmaceutical companies liable for introducing or causing the introduction into interstate commerce of adulterated or misbranded products. FDA Safety and Innovation Act explains that GMPs include owner?s ?implementation of oversight and controls over the manufacture of drugs to ensure quality, including managing the risk of and establishing the safety of raw materials used in the manufacturing of drugs, and finished drug products.? Additionally, new draft guidance on quality agreements, describes the responsibilities of drug manufacturers with respect to oversight of their suppliers. The seminar is a discussion of supplier management covering topics such as vendor qualification, supplier assessment, quality audits, supplier performance, and quality agreements.
Pejman Parhami completed his B.S. degree in Chemistry at the age of 20 from University of Oklahoma, and graduate studies in Chemistry from the same university. He also holds an MBA from Temple University. He is the director of Quality Systems, for Hyland?s, the largest and oldest homeopathic medicine manufacturer in the United States. He has over 27 years of experience in R&D and quality and has worked for AstraZeneca, GlaxoSmithKline, Cephalon, and MedImmune.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version